Last reviewed · How we verify
salbutamol sulfate and ipratropium bromide
salbutamol sulfate and ipratropium bromide is a Small molecule drug developed by Universidade Federal do Rio Grande do Norte. It is currently in Phase 1 development.
At a glance
| Generic name | salbutamol sulfate and ipratropium bromide |
|---|---|
| Sponsor | Universidade Federal do Rio Grande do Norte |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Magnesium Trial in Acute Asthma in Emergency Department (PHASE3)
- Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations (PHASE2)
- The Effect of Nebulized Epinephrine in Asthma Exacerbation in Pediatric Age Group With the Standard Treatment Compared to Standard Treatment Using Improvement PRAM Score as a Primary Outcome (PHASE4)
- Neural Respiratory Drive of Patients With Chronic Obstructive Pulmonary Disease (NA)
- A Comparative Study of Adding Ipratropium to Salbutamol for the Treatment of Asthma Attack in Children (PHASE4)
- Bronchodilators and Lung Mechanics During Exercise in COPD (PHASE4)
- Differential Mechanisms of Dyspnea Relief in Advanced COPD: Opiates vs. Bronchodilators (PHASE4)
- Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- salbutamol sulfate and ipratropium bromide CI brief — competitive landscape report
- salbutamol sulfate and ipratropium bromide updates RSS · CI watch RSS
- Universidade Federal do Rio Grande do Norte portfolio CI
Frequently asked questions about salbutamol sulfate and ipratropium bromide
What is salbutamol sulfate and ipratropium bromide?
salbutamol sulfate and ipratropium bromide is a Small molecule drug developed by Universidade Federal do Rio Grande do Norte.
Who makes salbutamol sulfate and ipratropium bromide?
salbutamol sulfate and ipratropium bromide is developed by Universidade Federal do Rio Grande do Norte (see full Universidade Federal do Rio Grande do Norte pipeline at /company/universidade-federal-do-rio-grande-do-norte).
What development phase is salbutamol sulfate and ipratropium bromide in?
salbutamol sulfate and ipratropium bromide is in Phase 1.